8-A12B/A: Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
Published on April 28, 1997
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________________________
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
OMEGA HEALTHCARE INVESTORS, INC.
(Exact name of registrant as specified in its charter)
MARYLAND 38-3041398
(State of Incorporation) (IRS Employer Identification No.)
905 WEST EISENHOWER CIRCLE, SUITE 110
ANN ARBOR, MICHIGAN 48103
(Address of principal executive offices)
SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12 (B) OF THE ACT:
9.25% SERIES A CUMULATIVE PREFERRED STOCK
(Title of each class to be registered)
NEW YORK STOCK EXCHANGE
(Name of each exchange on which each class is to be registered)
If this Form relates to the registration of a class of debt securities and is
effective upon filing pursuant to General Instruction A(c)(1) please check the
following box: [ ]
If this Form relates to the registration of a class of debt securities and is
to become effective simultaneously with the effectiveness of a concurrent
registration statement under the Securities Act of 1933 pursuant to General
Instruction A(c)(2) please check the following box: [ ]
SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(G) OF THE ACT:
NONE
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
A description of the 9.25% Series A Cumulative Preferred Stock (the
"Series A Preferred Stock") to be registered hereunder is contained in the
section entitled, "Description of Preferred Stock" on pages 7 through 11 of the
Prospectus included in the Registrant's Form S-3 Registration Statement, No.
333-20967, as filed on February 3, 1997, and as declared effective on February
14, 1997 by the Securities and Exchange Commission, and as supplemented in the
section entitled, "Description of Series A Preferred Stock" on pages S-18
through S-25 of the Preliminary Prospectus Supplement dated April 22, 1997 and
filed pursuant to Rule 424(b) of the Securities Act of 1933, as amended. Such
description is incorporated herein by reference.
ITEM 2. EXHIBITS.
Exhibit
Number Description
- ------ -----------
2.1 Articles of Incorporation, as amended, of the Registrant, filed as
Exhibit 3.1 to the Registrant's Form 10-Q for the quarter ended
March 31, 1995 and incorporated herein by reference.
2.2 Amended and Restated Bylaws of the Registrant, as amended
August 17, 1993 (filed as Exhibit 3.2 to the Company's Registration
Statement on Form S-4 (#33-70612) dated October 21, 1993), and
incorporated herein by reference.
2.3 Form of Articles Supplementary Classifying the 9.25% Series A
Cumulative Preferred Stock, filed as Exhibit 4.1 to Registrant's
Form 10-Q for the quarter ended March 31, 1997, and incorporated
herein by reference.
2.4 Specimen share certificate for 9.25% Series A Cumulative Preferred
Stock, filed as Exhibit 4.2 to Registration's Form 10-Q for the quarter
ended March 31, 1997, and incorporated herein by reference.
2
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, as amended, the Registrant has duly caused this Registration Statement
to be signed on its behalf by the undersigned, thereto duly authorized.
DATED: April 24, 1997 OMEGA HEALTHCARE INVESTORS, INC.
("Registrant")
By /s/ David A. Stover
------------------------------
David A. Stover, Vice President
and Chief Financial Officer
3